Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could psoriasis raise the risk of widespread pain?

NCT ID NCT07773766

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This study investigates whether adults with plaque psoriasis are more likely to have fibromyalgia and central sensitization—a condition where the nervous system becomes overly sensitive to pain—compared to healthy people. Researchers will compare 55 psoriasis patients with 55 matched healthy volunteers, using questionnaires to assess pain, fatigue, and quality of life. The goal is to understand how these conditions overlap, which could help doctors identify and manage pain in psoriasis patients earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds a strong link, it could lead to better early detection and management of chronic pain in people with psoriasis.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The findings may not apply to all psoriasis patients, and the small sample size limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult male and female patients (18 years of age and older) clinically diagnosed with plaque psoriasis who are attending the Dermatology Outpatient Clinic at Assiut University Hospital. It also includes a control group of apparently healthy, age- and sex-matched volunteers.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) with clinically diagnosed plaque psoriasis. * Both males and females. * Willing to participate and provide written informed consent. * For controls: Apparently healthy age- and sex-matched volunteers. * For controls: No history of psoriasis, psoriatic arthritis, or other chronic inflammatory or rheumatic diseases. * For controls: Willing to participate and provide written informed consent. Exclusion Criteria: * Patients with psoriatic arthritis or other inflammatory arthritis. * Patients with other diagnosed rheumatic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis). * Patients with previously diagnosed major depressive disorder or generalized anxiety disorder. * Patients with uncontrolled diabetes mellitus, heart failure, renal failure, or thyroid disorders. * Current use of antidepressants, anticonvulsants, or benzodiazepines. * History of malignancy. * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain fibromyalgia psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia Plaque psoriasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.